Sign In
Buy CCXI
$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
Are Options Traders Betting on a Big Move in ChemoCentryx (CCXI) Stock?
12:50pm, Tuesday, 07'th Jul 2020
Investors need to pay close attention to ChemoCentryx (CCXI) stock based on the movements in the options market lately.
Top Small Cap Stocks for July 2020
04:53pm, Monday, 29'th Jun 2020
Small cap stocks are listed companies that have market capitalizations typically ranging from $300 million to $2 billion. Since the share prices of these companies can have big fluctuations over a sh
ChemoCentryx Inc (NASDAQ:CCXI) Receives $71.63 Consensus Target Price from Analysts
08:50am, Monday, 29'th Jun 2020
ChemoCentryx Inc (NASDAQ:CCXI) has received a consensus recommendation of “Buy” from the twelve ratings firms that are covering the company, MarketBeat reports. One analyst has rated the stock wit
ChemoCentryx Inc (NASDAQ:CCXI) Shares Acquired by Geode Capital Management LLC
07:19am, Thursday, 25'th Jun 2020
Geode Capital Management LLC grew its position in ChemoCentryx Inc (NASDAQ:CCXI) by 10.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
Amazing recovery of boy with disease that made him 'swell up to twice his size'
01:38pm, Wednesday, 24'th Jun 2020
EXCLUSIVE: Dylan, 7, from Doncaster, was given a radical new treatment for Focal Segmental Glomerulosclerosis (FSGS) after his mum emailed a US doctor out of the blue asking for help in treating her s
ChemoCentryx Identifies Novel Orally Administered Immune Checkpoint Inhibitor CCX559 for Next Generation Cancer Treatment
12:30pm, Wednesday, 24'th Jun 2020
ChemoCentryx, Inc., (NASDAQ: CCXI) today announced that it has identified an orally administered checkpoint inhibitor, CCX559, and plans to initiate clinical
BNP Paribas Arbitrage SA Boosts Position in ChemoCentryx Inc (NASDAQ:CCXI)
07:40am, Friday, 19'th Jun 2020
BNP Paribas Arbitrage SA boosted its holdings in ChemoCentryx Inc (NASDAQ:CCXI) by 207.1% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The i
United States Diabetic Nephropathy Market and Competitive Landscape, 2020 - ResearchAndMarkets.com
12:00am, Wednesday, 17'th Jun 2020
The
ChemoCentryx, Inc. (CCXI) announced today the completion of its follow-on offering of 5,200,000 shares of its common stock. ChemoCentryx also announced today that the underwriters of its follow-on
ChemoCentryx Inc (NASDAQ:CCXI) Shares Bought by Federated Hermes Inc.
07:00am, Sunday, 14'th Jun 2020
Federated Hermes Inc. raised its holdings in ChemoCentryx Inc (NASDAQ:CCXI) by 128.1% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commis
Hedge Funds Have Never Been This Bullish On ChemoCentryx Inc (CCXI)
01:49pm, Friday, 12'th Jun 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
ChemoCentryx Prices Public Offering of Common Stock
01:33am, Thursday, 11'th Jun 2020
ChemoCentryx, Inc. (CCXI) announced today that it has priced an underwritten public offering of 5,200,000 shares of its common stock at a price to the public of $58.00 per share. The gross proceeds t
ChemoCentryx Announces Proposed Public Offering of Common Stock
08:08pm, Wednesday, 10'th Jun 2020
ChemoCentryx, Inc. (CCXI) announced today that it has commenced an underwritten public offering of its common stock. In connection with this offering, ChemoCentryx plans to grant the underwriters a 3
ChemoCentryx Files For Mixed Offering, Size Not Disclosed
08:05pm, Wednesday, 10'th Jun 2020Small Caps Build Steam And Biotechs Remain Well-Positioned
02:15pm, Wednesday, 10'th Jun 2020
Economic optimism has broadened the market rally. Small caps had lagged significantly and are now catching-up as they narrow the performance gap. The Federal Re
